COA Commends Senate Finance Committee for PBM Hearing

April 9, 2019

The Community Oncology Alliance (COA) is offering praise for the Senate Finance Committee over its pharmacy benefit manager (PBM) hearing, which COA called a reminder that PBMs refuse to acknowledge their role in rising drug costs.

The Community Oncology Alliance (COA) is offering praise for the Senate Finance Committee over its pharmacy benefit manager (PBM) hearing, which COA called a reminder that PBMs refuse to acknowledge their role in rising drug costs. COA also recommended additional work be done to shine a light on PBM abuses in delaying and/or denying cancer treatment for patients and that the House Energy & Commerce Committee hold hearings focused solely on PBMs.

COA voiced its support for the administration's proposal to eliminate PBM rebates in Medicare, as well as legislation to reign in PBM abuses, which includes recent legislation proposed that would bring ptice transparency to the prescription drug market and pass discuounts to consumers. Read the full press release.